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Synthesis of Phidianidine Analogues Containing a 1,2,3-triazole
David Laws III, Dillon King and Bryan H. Wakefield
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Phidianidines are a class of compound that has been extracted from the sea mollusk Phidianis militaris. These compounds have been
shown to exhibit a variety of useful properties such as antihistamine effects, anti-cancer activity, agonism of the µ-opioid receptor and
neuroprotection. The biological activities are thought to be caused by the 1,2,4- oxadiazole ring found within the molecule. The goal of
this project is to synthesize analogues of phidianidine that contain a 1,2,3-triazole instead of the 1,2,4 oxadiazole ring using a method
that will allow for other regions of the molecule to be changed. This will help to elucidate the role of the 1,2,4-oxadiazole ring in
biological activity as well as probe if the 1,2,3-triazole analogue can provide significant improvement to any activities.

Introduction
Marine organisms have been proven a rich source for bioactive
molecules over the last 50 years. Many of the marine natural products
discovered belong to a class of compounds called alkaloids.1-3 Alkaloids
are produced widely by both terrestrial and marine organisms and
evolved as a defense mechanism. For this reason alkaloids are often
cytotoxic. A subset of alkaloids, indole alkaloids, are important
compounds in the field of drug discovery that commonly possess
neurological activity.4,5 One such group of indole alkaloids are the
phidianidines, which were isolated by Gavagnin in 2011 from the sea
mollusk Phidianis militaris. Phidianidines A and B (Figure 1), which
differ based on the presence of a bromide, possess a unique 1,2,4oxadizole ring and biological properties.6
The phidianidines have a range of interesting bioactivity such as
anticancer6, HIV and neurological activity.7,8 Phidianidine A binds to the
chemokine receptor CXCR4. CXCR4 is an important target in the field
of pharmacology due to its involvement in HIV progression, tumor
development and metastasis, and rheumatoid arthritis. Phidianidine A
was shown to bind to CXCR4 moderately with hopes of improving its
activity.7 Additionally; the phidianidines have interesting applications in
neurological disorders. They function as a selective inhibitor of the
dopamine transporter and a selective ligand of the µ-opioid receptor.8
Selectivity among opioid receptors is important because the δ- and κopioid receptors are linked to addiction, while the µ-opioid receptor is
responsible for the analgesic effects.9,10 Other projects investigated the
neuroprotective activities of phidianidine derivatives, and found that 4substituted phidianidine derivatives offer significant protection against
hydrogen peroxide and oxygen-glucose deprivation in vitro which can
impact the onset and progression of neurodegenerative diseases like
Alzhiemer’s.11 Given these several important biological activities,
synthesis of phidianidine analogues are essential to understanding and
improving its functions.
Phidianidines are composed of three distinct regions, an indole, a
1,2,4-oxadiazole ring, and an aminoalkylguanidine chain. The bioactivity
is mainly thought to be a result of the 1,2,4-oxadiazole ring, and
phidianidine is the first isolated natural product to contain this structure.6
Previous synthesis of the phidianidines used a hydroxyguanidine linker
with a protected nitrogen and ethyl indole-3-acetate to form the 1,2,4oxadiazole ring.12,13 This has limited the ability of groups to explore the
affect of structural changes to the 1,2,4-oxadiazole and indole on the
biological activity. We hope to develop an approach to phidianidine
analogues that addresses this limitation.
The overall goal of this project is to synthesize a 1,2,3-triazole
analogue of the phidianidines (Figure 2) via cyclization of an azidogroup with a 3-propargyl indole.14 This approach will allow for the
impact of changes to the 1,2,4-oxadiazole ring and indole on the
molecule’s biological activity to be determined. The identification of
cyclization conditions to be used for the synthesis of the 1,2,3-triazole
analogues is reported herein.
Chemistry
In the reaction scheme, indole was reacted with propargyl bromide to
produce 3-propargyl indole (Scheme 1). This reaction was successfully
realized with a variety of indoles (Table 1). To determine the optimum
conditions for the synthesis of the 1,2,3-triazole heterocycle,

Figure 1. Structure of phidianidine A and B

Figure 2. The key step to the 1,2,3-triazole analogues of the
phidianidines

Scheme 1. Synthesis of 3-propargyl indoles

Table 1. Results of 3-propargyl indole syntheses
Entry
1
2
3
4
5

R
H
2-methyl
4-methyl
6-bromo
7-methyl

Yield
84%
43%
96%
87%
86%

Journal of the South Carolina Academy of Science, [2017], 15(2) | 5

Undergraduate Research Article
commercially available benzyl azide was used as a model (Scheme 2).
Treatment of the alkyne and azide under standard cycloaddition
conditions gave poor results15 (Table 2, entry 1). No product was
isolated though this could be due to difficulties in purification. In order
to improve the yield, the equivalents of the reactants were doubled and
the temperature increased to 60˚C. This provided moderate increases to
yield in some cases, however the yield was still around 30% (Table 2,
entries 2-4). The temperature and equivalents were increased again
(80˚C, 4 equiv.) however the yield decreased to 8% (Table 2, entry 5). It
was hypothesized that the low yields were caused by oxidation of the Cu
(I) catalyst by O2 gas within the solvent. The solvent was degassed with
bubbling N2; this led to the heterocycle being successfully synthesized in
59% yield (Table 2, entry 6). The cyclization was also tested with
various indoles with less success (Table 2, entries 7-10). Using benzyl
azide for the reaction allowed for reaction conditions to be developed,
but provided a truncated analogue of the natural product missing the
guanidine functionality. Work is currently underway to identify more
general cyclization conditions and to construct the azide needed to
synthesize the full analogue.

3-propargyl-2-methylindole
After completing the general procedure with 5 mL of benzene and 5
mmol of 2-methylindole, the residue was purified via flash
chromatography on SiO2 (1:9, EtOAc:Hexanes) to yield 0.24 g (43%).
1
H NMR (400 MHz, CDCl3) δ 7.82 (bs, 1 H), 7.68 (d, 1 H, J = 8.0 Hz),
7.24-7.14 (m, 3 H), 3.67 (s, 2 H), 2.47 (s, 3 H), 2.09-2.08 (m, 1 H).
6-bromo-3-propargylindole
After completing the general procedure with 5 mL of benzene and 5
mmol of 6-bromoindole, the residue was purified via flash
chromatography on SiO2 (1:9, EtOAc:Hexanes) to yield 0.66 g (87%) as
a dark brown solid. 1H NMR (400MHz, CDCl3) δ 8.02 (bs, 1 H), 7.537.49 (m, 2 H), 7.25 (d, 1 H, J = 8.4 Hz), 7.16 (s, 2 H), 2.17-2.14 (m, 1
H).
3-propargyl-7-methylindole
After completing the general procedure with 5 mL of benzene and 5
mmol of 7-methylindole, the residue was purified via flash
chromatography on SiO2 (1:9, EtOAc:Hexanes) to yield 0.47 g (86%) as
a brown solid. 1H NMR (400MHz, CDCl3) δ 8.01 (bs, 1 H), 7.59 (d, 1 H,
J = 7.6 Hz), 7.20-7.08 (m, 3 H), 3.8 (s, 2 H), 2.58 (s, 3 H), 2.24-2.23 (m,
1 H) .

Synthesis of 1,2,3-triazole with benzyl azide
To a mixture of 3-propargyl indole (50 mg, 0.30 mmol) in 4 mL of H2O:
tBuOH: DCM (2:2:1) was added benzyl azide (0.04 mL, 0.33 mmol) and
CuSO4 (7 mg, 0.04 mmol). The reaction was then degassed via bubbling
Scheme 2. Synthesis of the 1,2,3-triazole ring
N2 for 30 min. The reaction was then treated with sodium ascorbate (26
mg, 0.13 mmol) and stirred overnight. The organic was extracted with
DCM (3x), washed with brine, dried (MgSO4), filtered and concentrated
Methods
in vacuo.15 The residue was purified via chromatography on SiO2 (1:9 to
4:6 EtOAc:Hexanes) to yield 25 mg (59%) of an orange-brown oil. 1H
General Procedure for the synthesis of 3-propargyl indoles
A solution of 3.0 M MeMgI in ether (1.1 equiv) was added to benzene NMR (400MHz, CDCl3) δ 8.05 (bs, 1 H), 7.51 (d, 1 H, 7.6 Hz), 7.39and heated to 40 ˚C. To this solution was slowly added the appropriate 7.29 (m, 4 H), 7.24-7.16 (m, 3 H), 7.15-7.05 (m, 3 H), 5.45 (s, 2 H), 4.23
(s, 2 H).
indole in 2 mL benzene. After 10 min, propargyl bromide (0.7 equiv)
was added. The reaction stirred overnight at reflux then quenched with
NH4Cl, extracted with EtOAc (2x). The combined organic layers were Results and Conclusion
washed with brine, dried (MgSO4), filtered and concentrated in vacuo.16
The initial steps toward the synthesis of 1,2,3-triazole analogues of
3-propargylindole
phidianidine have been realized. Addition of propargyl to the 3-position
After completing the general procedure with 20 mL of benzene and 20 of indole has been achieved with variety of indoles, with yields between
mmol of indole, the residue was purified via flash chromatography on 80-90%. This opens a route for a variety of 1,2,3-triazole analogues to
SiO2 (1:9, EtOAc:Hexanes) to yield 1.72 g (84%) as a red-brown oil. 1H be synthesized from various indoles. Synthesis of the 1,2,3-triazole
NMR (400 MHz, CDCl3) δ 8.04 (bs, 1 H), 7.66 (d, 1 H, J = 8.0 Hz), 7.38 heterocycle was realized with 59% yield though more work is needed to
(d, 1 H, J = 8.0 Hz), 7.25-7.19 (m, 2 H), 7.16 (t, 1H, J = 8.0 Hz), 3.72 (s, expand the substrate scope. In addition to this, the synthesis of an azide
2 H), 2.17-2.14 (m, 1 H).
that will yield guanidine side chain is ongoing.
Table 2. Optimization of the cycloaddition reaction
Entry

R

Benzyl Azide
equiv.

Sodium
Ascorbate
equiv.

CuSO4
equiv.

Temp

Yield

1

H

1.1

0.45

0.15

RT

----------

2

H

2.2

0.9

0.3

60˚C

31%

3

H

2.2

0.9

0.3

60˚C

35%

4

H

2.2

0.9

0.3

60˚C

8%

5
6
7

H
H
H

4.4
1.1
2.2

1.8
0.45
0.9

0.6
0.15
0.3

80˚C
RT
60˚C

28%
59%
8%

8
9
10

6-bromo
7-methyl
2-methyl

1.1
1.1
1.1

0.45
0.45
0.45

0.15
0.15
0.15

RT
RT
RT

17%
25%
14%
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